Montefiore Medical Center
Bronx, NY
Accepting patients
Venetoclax Plus Intensive Chemotherapy
Phase 1B Study of Venetoclax in Combination With Standard Intensive Chemotherapy With Daunorubicin Plus Cytarabine Followed by High-Dose Cytarabine in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia and Advanced Myelodysplastic Syndrome
- BCL-2 Inhibitor
- Chemotherapy
- Phase 1
Not yet accepting
ARC-T Cells Plus SPRX002
Master Protocol for the Phase 1 Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome, Including Long-term Safety Follow-up
- CAR T Cell
- Phase 1